Guiding Therapy with Clinical Pearls and Expert Insights

How does HBsAb indicate immunity to HBV?

Understanding Hepatitis B Surface Antibody (HBsAb) and Immunity

Understanding Hepatitis B Surface Antibody (HBsAb) and Immunity

The Hepatitis B surface antibody (HBsAb) test is a crucial diagnostic tool used to determine immunity to the hepatitis B virus (HBV). Here’s how HBsAb indicates immunity:
  1. Positive HBsAb Test Result:
      • A positive or "reactive" HBsAb test result indicates the presence of surface antibodies in the blood. This typically means that the person has either recovered from a past HBV infection or has been successfully vaccinated against hepatitis B. In both cases, the presence of HBsAb suggests that the immune system has developed a protective response against the virus, providing immunity and preventing future infections[1][3][4].
  1. Mechanism of Immunity:
      • The immune system produces HBsAb in response to exposure to the hepatitis B surface antigen (HBsAg), either through natural infection or vaccination. These antibodies can neutralize the virus, preventing it from infecting liver cells and causing disease. The presence of HBsAb is a marker of the body's ability to recognize and combat HBV if exposed again[1][3].
  1. Role in Seroconversion:
      • In patients with chronic HBV infection, the presence of HBsAb-specific B cells can predict the likelihood of HBsAg seroconversion, which is a key indicator of successful antiviral therapy. Effective B-cell responses, including the secretion of HBsAb, are essential for clearing the virus and achieving long-term immunity[2].
  1. Interpretation of Test Results:
      • A positive HBsAb result alone indicates immunity due to vaccination.
      • If both HBsAb and hepatitis B core antibody (HBcAb) are positive, it suggests immunity due to past natural infection.
      • A negative HBsAb result means the person is not immune and may need vaccination[1][3][4].
Did you find this clinical pearl helpful?